FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1303962003: Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5308699017 Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5308700016 Aluminum hydroxide 35 mg/mL and magnesium hydroxide 40 mg/mL and simethicone 5 mg/mL oral suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5308701017 Aluminium hydroxide 35 mg/mL and magnesium hydroxide 40 mg/mL and simeticone 5 mg/mL oral suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Is a Aluminium hydroxide and magnesium hydroxide and simeticone only product in oral dose form true Inferred relationship Some
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Has manufactured dose form Oral suspension true Inferred relationship Some
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role Laxative therapeutic role false Inferred relationship Some
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Aluminium hydroxide true Inferred relationship Some 1
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Aluminium hydroxide true Inferred relationship Some 1
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 1
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Magnesium hydroxide (substance) true Inferred relationship Some 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Magnesium hydroxide (substance) true Inferred relationship Some 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Simeticone true Inferred relationship Some 3
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Simeticone true Inferred relationship Some 3
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 3
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start